l-glutamic acid di tert butyl ester hydrochloride glutathione acid-𝑁-Fmoc, γ-𝑡-butyl (¹³C₅, 99%; ¹⁵N, 99%) CP 96% *The following information Fmoc-Glu(OtBu)-OH, N-Fmoc-L-gluatmic acid gamma-t-butyl ester;

[0380] Anti- ALPP/ ALPPL2 immunoconjugates can be formed by conjugating the antibodies or antigen binding portions thereof described herein to an effector (e.g., a detectable label, another therapeutic agent, etc.)

heart tissue, spleen and serum was saved at 80 C till analysis

Dosing and Administration Standard Dose : 50 mg once daily or as directed by a licensed healthcare provider Route : Oral capsule Timing : Preferably taken in the morning with or without food Duration : Often used in 48 week cycles depending on clinical goals Because 5-Amino-1MQ modulates key metabolic pathways, it is strongly recommended that patients be monitored by a practitioner, especially when used alongside other metabolic or NAD therapies

26 SharmaK.SchmittS.BergnerC